Structure Therapeutics Inc. (GPCR)

NASDAQ: GPCR · Real-Time Price · USD

20.53

-0.21 (-1.01%)

At close: Jul 1, 2025, 4:00 PM

20.51

-0.02 (-0.10%)

After-hours: Jul 1, 2025, 4:04 PM EDT

Structure Therapeutics Employees

Structure Therapeutics had 163 employees as of December 31, 2024. The number of employees increased by 70 or 75.27% compared to the previous year.

Employees

163

Change (1Y)

70

Growth (1Y)

75.27%

Revenue / Employee

n/a

Profits / Employee

-$879,282

Market Cap

1.18B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	163	70	75.27%
Dec 31, 2023	93	25	36.76%
Dec 31, 2022	68	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000
AbbVie	55,000

Employee Rankings

GPCR News

10 days ago - Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671 - GlobeNewsWire
2 months ago - What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday? - Benzinga
3 months ago - Biotech stocks have been hit hard. Why they're a great value now. - Market Watch
3 months ago - Structure: A Lot Riding On Next Data Readout For Oral GLP-1 Candidate - Seeking Alpha
5 months ago - Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences - GlobeNewsWire
6 months ago - Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst - Benzinga
7 months ago - Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity - GlobeNewsWire
8 months ago - Structure Therapeutics to Participate in the Jefferies London Healthcare Conference - GlobeNewsWire